Varun Mehta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Varun Mehta has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ajit Sood
Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
2 shared publicationsArshdeep Singh
Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
2 shared publicationsAmninder Kaur
Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, India
1 shared publication- Arshdeep Singh
Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India
1 shared publication Chandan Kakkar
Department of Radiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
1 shared publicationHardeep Bains
Department of Surgery, Dayanand Medical College and Hospital, Ludhiana, India
1 shared publication
Latest Publications
- Open Access
- 1 April 2023
- Published by Medknow in Indian Journal of Pathology and Microbiology
- Vol. 66 (2) , 385-387
Fibrolamellar hepatocellular carcinoma presenting as cholestatic jaundice
Fibrolamellar hepatocellular carcinoma is a rare primary hepatic tumor that usually occurs in youth. The common presenting features are vague abdominal pain, nausea, vomiting and weight loss. We present a case report of a young male who presented with cholestatic jaundice and on evaluation was diagnosed to have fibrolamellar hepatocellular carcinoma. He underwent successful surgical resection of the tumor. In young individuals presenting with unexplained cholestasis, fibrolamellar hepatocellular carcinoma should be considered.
- 1 April 2023
- Published by Medknow in Indian Journal of Pathology and Microbiology
- Vol. 66 (2) , 385-387
Open AccessFibrolamellar hepatocellular carcinoma presenting as cholestatic jaundice
Fibrolamellar hepatocellular carcinoma is a rare primary hepatic tumor that usually occurs in youth. The common presenting features are vague abdominal pain, nausea, vomiting and weight loss. We present a case report of a young male who presented with cholestatic jaundice and on evaluation was diagnosed to have fibrolamellar hepatocellular carcinoma. He underwent successful surgical resection of the tumor. In young individuals presenting with unexplained cholestasis, fibrolamellar hepatocellular carcinoma should be considered.
- 1 March 2022
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 12 (2) , 409-416
Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
- 1 March 2022
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 12 (2) , 409-416
Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
- Open Access
- 25 July 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (2) , 184-187
Role of percutaneous catheter drainage as primary treatment of necrotizing pancreatitis
Background/Aims: Necrotizing pancreatitis has morbidity and mortality rates exceeding most of the other acute medical emergencies despite the best possible medical and surgical care. Early surgical intervention has a high operative risk. Materials and Methods: This prospective open-label study was designed to evaluate the role of percutaneous catheter drainage (PCD) of pancreatic necrosis as primary treatment of acute necrotizing pancreatitis. An ultrasound/computed tomography-guided drainage was performed with 10 or 12 Fr catheters using a 0.35 mm guide wire, irrespective of whether necrosis was infected or not. Patients were followed up for organ dysfunction, need for surgical intervention, and survival at week 8. Results: A total of 20 (65% males) patients who had acute necrotizing pancreatitis with varied etiology were enrolled in the present study. Of these patients, 9 (45%) did not need surgery after PCD. The remaining 11 (55%) patients showed significant reversal of organ failure after PCD insertion (pConclusion: Percutaneous catheter drainage can be a primary treatment option for necrotizing pancreatitis. In addition, it helps to stabilize critically ill patients and delay the surgical procedure to beyond 4 weeks to improve the surgical outcomes. Cite this article as: Mehta V, Kumar R, Parkash S, et al. Role of percutaneous catheter drainage as primary treatment of necrotizing pancreatitis. Turk J Gastroenterol 2019; 30(2): 184-7.
- 25 July 2019
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 30 (2) , 184-187
Open AccessRole of percutaneous catheter drainage as primary treatment of necrotizing pancreatitis
Background/Aims: Necrotizing pancreatitis has morbidity and mortality rates exceeding most of the other acute medical emergencies despite the best possible medical and surgical care. Early surgical intervention has a high operative risk. Materials and Methods: This prospective open-label study was designed to evaluate the role of percutaneous catheter drainage (PCD) of pancreatic necrosis as primary treatment of acute necrotizing pancreatitis. An ultrasound/computed tomography-guided drainage was performed with 10 or 12 Fr catheters using a 0.35 mm guide wire, irrespective of whether necrosis was infected or not. Patients were followed up for organ dysfunction, need for surgical intervention, and survival at week 8. Results: A total of 20 (65% males) patients who had acute necrotizing pancreatitis with varied etiology were enrolled in the present study. Of these patients, 9 (45%) did not need surgery after PCD. The remaining 11 (55%) patients showed significant reversal of organ failure after PCD insertion (pConclusion: Percutaneous catheter drainage can be a primary treatment option for necrotizing pancreatitis. In addition, it helps to stabilize critically ill patients and delay the surgical procedure to beyond 4 weeks to improve the surgical outcomes. Cite this article as: Mehta V, Kumar R, Parkash S, et al. Role of percutaneous catheter drainage as primary treatment of necrotizing pancreatitis. Turk J Gastroenterol 2019; 30(2): 184-7.